Navigation Links
Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call
Date:3/2/2009

BOTHELL, Wash., March 2 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it will release its fourth quarter 2008 financial results on Thursday, March 12, 2009 after the market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time. During the call, Cardiac Science management will discuss the financial results for the fourth quarter as well as the current business outlook.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

To access the conference call, please dial 800-257-3401. International participants can dial 303-262-2125. The call will also be webcast live at www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11125955#. An archived webcast will also be available at www.cardiacscience.com for 90 days.

    For more information,
    Company Contact:               Investor Contact:        Media Contact:
    Mike Matysik                   Doug Sherk               Christopher Gale
    Cardiac Science Corporation    Jenifer Kirtland         EVC Group, Inc.
    Sr. Vice President and CFO     EVC Group, Inc.          (646) 201-5431
    (425) 402-2009                 (415) 896-6820           (203) 570-4681
                                                            cgale@evcgroup.com

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit www.cardiacscience.com.

CSCX-F


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
2. Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference
3. Sudden Cardiac Death Rare in Young Athletes
4. Global Economic Meltdown - Is the European Cardiac Rhythm Management Market Spared?
5. TV News Coverage Reports on InnerCools CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago
6. Worlds First Cardiac Adult Stem Cell Trial to Take Place in Louisville
7. iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies
8. Cardiac Science Increases R&D Capacity With 3-year Syncroness Agreement
9. The Sudden Cardiac Arrest Association Shoots Straight for the Heart
10. Experts Urge Limits on Use of Cardiac CT Scans
11. Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 2017 , ... Doctors on Liens is continuing its steady expansion of medical ... practicing at North Valley Eye Medical Group in Mission Hills . Eye injuries ... personal injury cases. These injuries have a major impact on the quality of ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... country today, as organizations, advocates, and individuals join together to increase recognition about ... to ultimately save lives. , “Today we mark a nationwide movement to raise ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers ... to help small practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare ... Access and CHIP Reauthorization Act of 2015 (MACRA). , This technical assistance, ...
(Date:2/22/2017)... ... 22, 2017 , ... Bellus Medical, a leader in medical ... delivery of Platelet Rich Plasma (PRP). PRP systems are used by physicians in ... synthesis and provide a faster and more efficient healing process. There are many ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Research and Markets has announced the addition of ... report to their offering. ... Dermatological conditions are one of the ... the US population suffers from at least one active skin ... market has remained saturated with established and generic products. However, ...
(Date:2/22/2017)... , Feb. 22, 2017   Protein Sciences Corporation ... Flublok® Influenza Vaccine , announced today that they ... Influenza Vaccine Introduction (PIVI) and the Mongolian Ministry of ... of the flu.  The doses of Flublok have been ... Mongolia for health care workers, pregnant women, ...
(Date:2/22/2017)... February 22, 2017 A research report by ... America and the continuously changing landscape of the legal ... in the North America , a 30% increase ... to $21.6 billion by the year 2021 representing a 26 percent ... the United States and Canada ...
Breaking Medicine Technology: